Published in J Am Coll Cardiol on March 01, 1992
Detection of apical hypertrophic cardiomyopathy by cardiovascular magnetic resonance in patients with non-diagnostic echocardiography. Heart (2004) 2.22
Echocardiographic pitfalls in the diagnosis of hypertrophic cardiomyopathy. Heart (1999) 1.45
Decreased maximal aerobic capacity in pediatric chronic kidney disease. J Am Soc Nephrol (2008) 1.01
Left ventricular strain and untwist in hypertrophic cardiomyopathy: relation to exercise capacity. Am Heart J (2010) 0.87
Clinical significance of N-terminal-probrain natriuretic peptide in hypertrophic cardiomyopathy. Heart Vessels (2007) 0.85
Elevated carbohydrate antigen 125 levels in hypertrophic cardiomyopathy patients with heart failure. Heart Vessels (2007) 0.81
Reduction of left ventricular longitudinal global and segmental systolic functions in patients with hypertrophic cardiomyopathy: Study of two-dimensional tissue motion annular displacement. Exp Ther Med (2014) 0.79
Relationship between baseline resting diastolic function and exercise capacity in patients with hypertrophic cardiomyopathy undergoing treadmill stress echocardiography: a cohort study. BMJ Open (2012) 0.77
Effects of hypertrophy and fibrosis on regional and global functional heterogeneity in hypertrophic cardiomyopathy. Int J Cardiovasc Imaging (2012) 0.77
Hypertrophic Cardiomyopathy in a Young Adult with RV Aneurysm: Report of a Rare Finding and Review of the Literature. Heart Views (2011) 0.75
Diastolic function in hypertrophic cardiomyopathy. J Am Coll Cardiol (1992) 0.75
Short- and long-term effects of nisoldipine on cardiac function and exercise tolerance in patients with hypertrophic cardiomyopathy. Basic Res Cardiol (1997) 0.75
Frequency of risk factors for ischaemic heart-disease in a healthy British population. With particular reference to serum-lipoprotein levels. Lancet (1974) 8.19
Missense mutations in the rod domain of the lamin A/C gene as causes of dilated cardiomyopathy and conduction-system disease. N Engl J Med (1999) 5.61
Identification of a deletion in plakoglobin in arrhythmogenic right ventricular cardiomyopathy with palmoplantar keratoderma and woolly hair (Naxos disease). Lancet (2000) 4.54
Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance. Circulation (2003) 4.48
Mutations in the genes for cardiac troponin T and alpha-tropomyosin in hypertrophic cardiomyopathy. N Engl J Med (1995) 4.37
The management of hypertrophic cardiomyopathy. N Engl J Med (1997) 4.15
Spectrum of clinicopathologic manifestations of arrhythmogenic right ventricular cardiomyopathy/dysplasia: a multicenter study. J Am Coll Cardiol (1997) 3.64
The microbiology and pathogenesis of infective endocarditis. Br Heart J (1983) 3.36
Prevalence of Anderson-Fabry disease in male patients with late onset hypertrophic cardiomyopathy. Circulation (2002) 3.22
The cardiomyopathies. Br Heart J (1972) 3.14
Side effects of long-term amiodarone therapy. Circulation (1983) 3.03
Relation between severity of left-ventricular hypertrophy and prognosis in patients with hypertrophic cardiomyopathy. Lancet (2001) 3.02
Mutations in the cardiac myosin binding protein-C gene on chromosome 11 cause familial hypertrophic cardiomyopathy. Nat Genet (1995) 2.97
Task Force on Sudden Cardiac Death of the European Society of Cardiology. Eur Heart J (2001) 2.93
Sudden death in hypertrophic cardiomyopathy: identification of high risk patients. J Am Coll Cardiol (2000) 2.89
Primary restrictive cardiomyopathy. Non-tropical endomyocardial fibrosis and hypereosinophilic heart disease. Br Heart J (1977) 2.68
Novel organ-specific circulating cardiac autoantibodies in dilated cardiomyopathy. J Am Coll Cardiol (1990) 2.67
Acute subvalvar mitral incompetence. Lancet (1966) 2.65
Cardiac fatigue following prolonged endurance exercise of differing distances. Med Sci Sports Exerc (2000) 2.47
Percutaneous catheter fragmentation and distal dispersion of proximal pulmonary embolus. Lancet (1991) 2.36
Distribution of left ventricular hypertrophy in hypertrophic cardiomyopathy: a two-dimensional echocardiographic study. J Am Coll Cardiol (1983) 2.34
Electrocardiographic changes in 1000 highly trained junior elite athletes. Br J Sports Med (1999) 2.32
Expression of inducible nitric oxide synthase in human heart failure. Circulation (1996) 2.26
Enhanced basal nitric oxide production in heart failure: another failed counter-regulatory vasodilator mechanism? Lancet (1994) 2.25
Guidelines for the study of familial dilated cardiomyopathies. Collaborative Research Group of the European Human and Capital Mobility Project on Familial Dilated Cardiomyopathy. Eur Heart J (1999) 2.24
Detection of apical hypertrophic cardiomyopathy by cardiovascular magnetic resonance in patients with non-diagnostic echocardiography. Heart (2004) 2.22
Improved survival with amiodarone in patients with hypertrophic cardiomyopathy and ventricular tachycardia. Br Heart J (1985) 2.22
A randomized controlled trial of epoprostenol therapy for severe congestive heart failure: The Flolan International Randomized Survival Trial (FIRST). Am Heart J (1997) 2.16
Familial dilated cardiomyopathy: cardiac abnormalities are common in asymptomatic relatives and may represent early disease. J Am Coll Cardiol (1998) 2.03
Regression of primary pulmonary hypertension. Br Heart J (1976) 2.03
Prevalence of exercise-induced left ventricular outflow tract obstruction in symptomatic patients with non-obstructive hypertrophic cardiomyopathy. Heart (2007) 1.97
Clinical features of fifteen patients with the hypereosinophilic syndrome. Q J Med (1983) 1.96
Tumour necrosis factor and inducible nitric oxide synthase in dilated cardiomyopathy. Lancet (1996) 1.95
Cardiac abnormalities in systemic lupus erythematosus. Association with raised anticardiolipin antibodies. Circulation (1990) 1.91
Arrhythmia in hypertrophic cardiomyopathy. I: Influence on prognosis. Br Heart J (1981) 1.91
Atrial fibrillation in hypertrophic cardiomyopathy: a longitudinal study. J Am Coll Cardiol (1990) 1.91
Eosinophilia and heart disease. Br Heart J (1977) 1.90
Infective endocarditis. Br J Hosp Med (1980) 1.88
Antibodies to Coxsackie B viruses in congestive cardiomyopathy. Br Heart J (1979) 1.86
Echocardiography of the mitral valve in aortic valve disease. Br Heart J (1971) 1.86
High-density substrate mapping in Brugada syndrome: combined role of conduction and repolarization heterogeneities in arrhythmogenesis. Circulation (2009) 1.83
Assessment of site and severity in congenital aortic stenosis. Br Heart J (1967) 1.83
Assessment of permanent dual-chamber pacing as a treatment for drug-refractory symptomatic patients with obstructive hypertrophic cardiomyopathy. A randomized, double-blind, crossover study (M-PATHY). Circulation (1999) 1.76
Relation between myocyte disarray and outcome in hypertrophic cardiomyopathy. Am J Cardiol (2001) 1.74
Right ventricular dilated cardiomyopathy. Br Heart J (1984) 1.74
Abnormal blood pressure response during exercise in hypertrophic cardiomyopathy. Circulation (1990) 1.73
M mode echocardiography in hypertrophic cardiomyopathy: diagnostic criteria and prediction of obstruction. Am J Cardiol (1980) 1.72
Familial dilated cardiomyopathy: evidence for genetic and phenotypic heterogeneity. Heart Muscle Disease Study Group. J Am Coll Cardiol (1999) 1.71
Cadiovascular complications of homozygous familial hypercholesterolaemia. Br Heart J (1980) 1.69
Prognostic implications of novel beta cardiac myosin heavy chain gene mutations that cause familial hypertrophic cardiomyopathy. J Clin Invest (1994) 1.69
Left ventricular hypertrophy and morphology in familial hypertrophic cardiomyopathy associated with mutations of the beta-myosin heavy chain gene. J Am Coll Cardiol (1993) 1.68
Hypertrophic cardiomyopathy: the interrelation of disarray, fibrosis, and small vessel disease. Heart (2000) 1.66
Effects of increased inspired oxygen concentrations on exercise performance in chronic heart failure. Lancet (1992) 1.65
Management of pregnancy in patients with hypertrophic cardiomyopathy. Br Med J (1979) 1.64
Hypertrophic cardiomyopathy: histopathological features of sudden death in cardiac troponin T disease. Circulation (2001) 1.64
Analysis of symptomatic course and prognosis and treatment of hypertrophic obstructive cardiomyopathy. Br Heart J (1971) 1.63
QT dispersion and RR variations on 12-lead ECGs in patients with congestive heart failure secondary to idiopathic dilated cardiomyopathy. Eur Heart J (1996) 1.63
Cardiovascular features of 11 patients with eosinophilic endomyocardial disease. Q J Med (1983) 1.62
The bowel, the genitourinary tract, and infective endocarditis. Br Heart J (1984) 1.62
Congenital fistula between the aorta and left atrium. Br Heart J (1987) 1.61
Clinical significance of giant negative T waves in hypertrophic cardiomyopathy. J Am Coll Cardiol (1990) 1.60
Natural history of secundum atrial septal defect in adults after medical or surgical treatment: a historical prospective study. Br Heart J (1994) 1.59
A disease locus for familial hypertrophic cardiomyopathy maps to chromosome 1q3. Nat Genet (1993) 1.57
Homozygous mutation of desmocollin-2 in arrhythmogenic right ventricular cardiomyopathy with mild palmoplantar keratoderma and woolly hair. Cardiology (2008) 1.57
Mechanisms of exercise limitation in hypertrophic cardiomyopathy. J Am Coll Cardiol (1992) 1.57
Infective endocarditis in three patients with hypertrophic obstructive cardiomyopathy. Br Med J (1968) 1.56
Cine angiography of left ventricular aneurysms. Clin Radiol (1972) 1.53
Beta-adrenergic blockade in hypertrophic obstructive cardiomyopathy. Br Med J (1966) 1.53
Is aspirin safe for patients with heart failure? Br Heart J (1995) 1.49
Association of angiotensin-converting enzyme gene I/D polymorphism with change in left ventricular mass in response to physical training. Circulation (1997) 1.48
Mechanism of mitral regurgitation in hypertrophic obstructive cardiomyopathy. Br Heart J (1970) 1.48
Clinical definitions and classification of cardiomyopathies. Postgrad Med J (1972) 1.47
Arrhythmia in hypertrophic cardiomyopathy. II: Comparison of amiodarone and verapamil in treatment. Br Heart J (1981) 1.46
Q waves in hypertrophic cardiomyopathy in relation to the distribution and severity of right and left ventricular hypertrophy. J Am Coll Cardiol (1990) 1.45
Echocardiographic pitfalls in the diagnosis of hypertrophic cardiomyopathy. Heart (1999) 1.45
Genetic and molecular basis of cardiac arrhythmias: impact on clinical management parts I and II. Circulation (1999) 1.44
Magnitude of myocardial dysfunction is greater in painful than in painless myocardial ischemia: an exercise echocardiographic study. J Am Coll Cardiol (1995) 1.44
Genetic testing for familial hypertrophic cardiomyopathy in newborn infants. BMJ (1995) 1.44
Usefulness of echocardiography to differentiate dilated cardiomyopathy from coronary-induced congestive heart failure. Am J Cardiol (1991) 1.43
Ventricular tachycardia of left bundle branch block configuration in patients with isolated right ventricular dilatation. Clinical and electrophysiological features. Br Heart J (1984) 1.42
Pregnancy in a patient with a mitral-valve prosthesis. Lancet (1968) 1.41
Factors that influence the outcome of primary pulmonary hypertension. Br Heart J (1986) 1.41
Reflex responses of venous capacitance vessels in patients with hypertrophic cardiomyopathy. Clin Sci (Lond) (1998) 1.41
Delayed improvement in exercise capacity after cardioversion of atrial fibrillation to sinus rhythm. Br Heart J (1988) 1.41
Side effects and possible contraindications of amiodarone use. Am Heart J (1983) 1.40
Human chagasic disease is not associated with an antiheart humoral response. Am J Cardiol (1997) 1.40
The diagnostic significance of reciprocal ST segment depression in acute myocardial infarction. Q J Med (1989) 1.40
Dispersion of ventricular repolarization is determined by the presence of myocardial viability in patients with old myocardial infarction. A dobutamine stress echocardiography study. Eur Heart J (2000) 1.39
Determinants of exercise capacity in patients with coronary artery disease and mild to moderate systolic dysfunction. Role of heart rate and diastolic filling abnormalities. Eur Heart J (1996) 1.39
Dental prophylaxis for endocarditis. Lancet (1992) 1.39
Chest pain during daily life in patients with hypertrophic cardiomyopathy: an ambulatory electrocardiographic study. Eur Heart J (1996) 1.39
Identification of alpha- and beta-cardiac myosin heavy chain isoforms as major autoantigens in dilated cardiomyopathy. Circulation (1992) 1.38
Ventricular fibrillation in hypertrophic cardiomyopathy is associated with increased fractionation of paced right ventricular electrograms. Circulation (1992) 1.38
Pregnancy complicated by cardiac valvular disease and hypertension. Problems of management. Chest (1991) 1.38